Ceribell, Inc. Research and Development Expense
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-10
- Ceribell, Inc. research and development expense for the quarter ending 2026-06-30 was $6.75M, a 39.06% increase year-over-year.
- Ceribell, Inc. research and development expense for the quarter ending 2026-03-31 was $6.16M, a 45.10% increase year-over-year.
- Ceribell, Inc. research and development expense for the quarter ending 2025-12-31 was $5.06M, a 29.36% increase year-over-year.
- Ceribell, Inc. research and development expense for the quarter ending 2025-09-30 was $4.98M, a 46.77% increase year-over-year.
- Ceribell, Inc. research and development expense for fiscal 2025 was $19.14M, a 41.15% increase from fiscal 2024.
- Ceribell, Inc. research and development expense for fiscal 2024 was $13.56M, a 50.77% increase from fiscal 2023.
- Ceribell, Inc. research and development expense for fiscal 2023 was $8.99M.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $6.75M 10-Q · filed 2026-08-10 | $12.91M 10-Q · filed 2026-08-10 | $17.97M derived: sum of 3 quarters · filed 2026-08-10 | $22.95M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $6.16M 10-Q · filed 2026-05-11 | $11.22M derived: sum of 2 quarters · filed 2026-05-11 | $16.21M derived: sum of 3 quarters · filed 2026-05-11 | $21.06M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $5.06M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $10.04M derived: sum of 2 quarters · filed 2026-02-24 | $14.90M derived: sum of 3 quarters · filed 2026-08-10 | $19.14M 10-K · filed 2026-02-24 |
| 2025-09-30 | $4.98M 10-Q · filed 2025-11-04 | $9.84M derived: sum of 2 quarters · filed 2026-08-10 | $14.08M 10-Q · filed 2025-11-04 | $17.99M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $4.85M 10-Q · filed 2026-08-10 | $9.10M 10-Q · filed 2026-08-10 | $13.01M derived: sum of 3 quarters · filed 2026-08-10 | $16.41M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $4.25M 10-Q · filed 2026-05-11 | $8.16M derived: sum of 2 quarters · filed 2026-05-11 | $11.55M derived: sum of 3 quarters · filed 2026-05-11 | $14.82M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $3.91M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $7.31M derived: sum of 2 quarters · filed 2026-02-24 | $10.58M derived: sum of 3 quarters · filed 2026-02-24 | $13.56M 10-K · filed 2026-02-24 |
| 2024-09-30 | $3.40M 10-Q · filed 2025-11-04 | $6.67M derived: sum of 2 quarters · filed 2025-11-04 | $9.65M 10-Q · filed 2025-11-04 | $12.34M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $3.27M 10-Q · filed 2025-08-05 | $6.25M 10-Q · filed 2025-08-05 | $8.94M derived: sum of 3 quarters · filed 2025-08-05 | $11.25M derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | $2.98M 10-Q · filed 2025-05-08 | $5.67M derived: sum of 2 quarters · filed 2025-05-08 | $7.98M derived: sum of 3 quarters · filed 2025-05-08 | |
| 2023-12-31 | $2.69M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $5.00M derived: sum of 2 quarters · filed 2025-02-25 | $8.99M 10-K · filed 2025-02-25 | |
| 2023-09-30 | $2.31M 10-Q · filed 2024-11-12 | $6.31M 10-Q · filed 2024-11-12 |